147 related articles for article (PubMed ID: 37156706)
1. PDE4 inhibition by difamilast regulates filaggrin and loricrin expression via keratinocyte proline-rich protein in human keratinocytes.
Tsuji G; Hashimoto-Hachiya A; Yumine A; Takemura M; Kido-Nakahara M; Ito T; Yamamura K; Nakahara T
J Dermatol Sci; 2023 May; 110(2):61-68. PubMed ID: 37156706
[TBL] [Abstract][Full Text] [Related]
2. IL-24 Negatively Regulates Keratinocyte Differentiation Induced by Tapinarof, an Aryl Hydrocarbon Receptor Modulator: Implication in the Treatment of Atopic Dermatitis.
Vu YH; Hashimoto-Hachiya A; Takemura M; Yumine A; Mitamura Y; Nakahara T; Furue M; Tsuji G
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321923
[TBL] [Abstract][Full Text] [Related]
3. Possible new therapeutic strategy to regulate atopic dermatitis through upregulating filaggrin expression.
Otsuka A; Doi H; Egawa G; Maekawa A; Fujita T; Nakamizo S; Nakashima C; Nakajima S; Watanabe T; Miyachi Y; Narumiya S; Kabashima K
J Allergy Clin Immunol; 2014 Jan; 133(1):139-46.e1-10. PubMed ID: 24055295
[TBL] [Abstract][Full Text] [Related]
4. Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis.
Tsuji G; Hashimoto-Hachiya A; Kiyomatsu-Oda M; Takemura M; Ohno F; Ito T; Morino-Koga S; Mitoma C; Nakahara T; Uchi H; Furue M
Cell Death Dis; 2017 Jul; 8(7):e2931. PubMed ID: 28703805
[TBL] [Abstract][Full Text] [Related]
5. Aryl Hydrocarbon Receptor Activation Downregulates IL-33 Expression in Keratinocytes via Ovo-Like 1.
Tsuji G; Hashimoto-Hachiya A; Yen VH; Miake S; Takemura M; Mitamura Y; Ito T; Murata M; Furue M; Nakahara T
J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32214018
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant Artemisia princeps Extract Enhances the Expression of Filaggrin and Loricrin via the AHR/OVOL1 Pathway.
Hirano A; Goto M; Mitsui T; Hashimoto-Hachiya A; Tsuji G; Furue M
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28892018
[TBL] [Abstract][Full Text] [Related]
7. Diosmin restores the skin barrier by targeting the aryl hydrocarbon receptor in atopic dermatitis.
Lee J; Song KM; Jung CH
Phytomedicine; 2021 Jan; 81():153418. PubMed ID: 33302042
[TBL] [Abstract][Full Text] [Related]
8. Keratinocyte Proline-Rich Protein Deficiency in Atopic Dermatitis Leads to Barrier Disruption.
Suga H; Oka T; Sugaya M; Sato Y; Ishii T; Nishida H; Ishikawa S; Fukayama M; Sato S
J Invest Dermatol; 2019 Sep; 139(9):1867-1875.e7. PubMed ID: 30905808
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of filaggrin deficiency identifies molecular signatures characteristic of atopic eczema.
Elias MS; Long HA; Newman CF; Wilson PA; West A; McGill PJ; Wu KC; Donaldson MJ; Reynolds NJ
J Allergy Clin Immunol; 2017 Nov; 140(5):1299-1309. PubMed ID: 28479159
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of filaggrin regulates endogenous cysteine protease activity, leading to impaired skin barrier function.
Wang XW; Wang JJ; Gutowska-Owsiak D; Salimi M; Selvakumar TA; Gwela A; Chen LY; Wang YJ; Giannoulatou E; Ogg G
Clin Exp Dermatol; 2017 Aug; 42(6):622-631. PubMed ID: 28556377
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological Profile of Difamilast, a Novel Selective Phosphodiesterase 4 Inhibitor, for Topical Treatment of Atopic Dermatitis.
Hiyama H; Arichika N; Okada M; Koyama N; Tahara T; Haruta J
J Pharmacol Exp Ther; 2023 Jul; 386(1):45-55. PubMed ID: 37041087
[TBL] [Abstract][Full Text] [Related]
12. GSDMD suppresses keratinocyte differentiation by inhibiting FLG expression and attenuating KCTD6-mediated HDAC1 degradation in atopic dermatitis.
Zhong Y; Huang T; Li X; Luo P; Zhang B
PeerJ; 2024; 12():e16768. PubMed ID: 38250727
[TBL] [Abstract][Full Text] [Related]
13. Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin.
Pellerin L; Henry J; Hsu CY; Balica S; Jean-Decoster C; Méchin MC; Hansmann B; Rodriguez E; Weindinger S; Schmitt AM; Serre G; Paul C; Simon M
J Allergy Clin Immunol; 2013 Apr; 131(4):1094-102. PubMed ID: 23403047
[TBL] [Abstract][Full Text] [Related]
14. Topical Application of a PDE4 Inhibitor Ameliorates Atopic Dermatitis through Inhibition of Basophil IL-4 Production.
Takahashi K; Miyake K; Ito J; Shimamura H; Suenaga T; Karasuyama H; Ohashi K
J Invest Dermatol; 2024 May; 144(5):1048-1057.e8. PubMed ID: 37827277
[TBL] [Abstract][Full Text] [Related]
15. A mechanistic target of rapamycin complex 1/2 (mTORC1)/V-Akt murine thymoma viral oncogene homolog 1 (AKT1)/cathepsin H axis controls filaggrin expression and processing in skin, a novel mechanism for skin barrier disruption in patients with atopic dermatitis.
Naeem AS; Tommasi C; Cole C; Brown SJ; Zhu Y; Way B; Willis Owen SA; Moffatt M; Cookson WO; Harper JI; Di WL; Brown SJ; Reinheckel T; O'Shaughnessy RF
J Allergy Clin Immunol; 2017 Apr; 139(4):1228-1241. PubMed ID: 27913303
[TBL] [Abstract][Full Text] [Related]
16. Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency.
Kezic S; O'Regan GM; Lutter R; Jakasa I; Koster ES; Saunders S; Caspers P; Kemperman PM; Puppels GJ; Sandilands A; Chen H; Campbell LE; Kroboth K; Watson R; Fallon PG; McLean WH; Irvine AD
J Allergy Clin Immunol; 2012 Apr; 129(4):1031-9.e1. PubMed ID: 22322004
[TBL] [Abstract][Full Text] [Related]
17. Nuclear IL-33 Plays an Important Role in the Suppression of FLG, LOR, Keratin 1, and Keratin 10 by IL-4 and IL-13 in Human Keratinocytes.
Dai X; Utsunomiya R; Shiraishi K; Mori H; Muto J; Murakami M; Sayama K
J Invest Dermatol; 2021 Nov; 141(11):2646-2655.e6. PubMed ID: 33865911
[TBL] [Abstract][Full Text] [Related]
18. GATA3 regulates FLG and FLG2 expression in human primary keratinocytes.
Zeitvogel J; Jokmin N; Rieker S; Klug I; Brandenberger C; Werfel T
Sci Rep; 2017 Sep; 7(1):11847. PubMed ID: 28928464
[TBL] [Abstract][Full Text] [Related]
19. Transient receptor potential vanilloid 1 plays a major role in low temperature-mediated skin barrier dysfunction.
Kim BE; Hui-Beckman J; Lyubchenko T; Hall CF; Fallahi S; Brull A; Goleva E; Leung DYM
J Allergy Clin Immunol; 2022 Aug; 150(2):362-372.e7. PubMed ID: 35189126
[TBL] [Abstract][Full Text] [Related]
20. Loss of sirtuin 1 (SIRT1) disrupts skin barrier integrity and sensitizes mice to epicutaneous allergen challenge.
Ming M; Zhao B; Shea CR; Shah P; Qiang L; White SR; Sims DM; He YY
J Allergy Clin Immunol; 2015 Apr; 135(4):936-945.e4. PubMed ID: 25445829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
